Working... Menu

A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen) (ProScreen)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03423303
Recruitment Status : Enrolling by invitation
First Posted : February 6, 2018
Last Update Posted : May 3, 2018
Helsinki University Hospital, Finland
Tampere University Hospital, Finland
Finnish Cancer Registry, Finland
University of Turku, Finland
Lund University
Fimlab Laboratories, Finland
Laboratory HUSLAB, Finland
Helsinki University
Hospital District of Helsinki and Uusimaa
Clinical Research Institute HUCH Ltd, Finland
Information provided by (Responsible Party):
Anssi Auvinen, Tampere University

No Study Results Posted on for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : December 31, 2028
  Estimated Study Completion Date : December 31, 2028